Anuh Pharma has inaugurated its new manufacturing unit, Block INT-1A, at MIDC, Tarapur, Boisar, in Palghar district, Maharashtra. In a regulatory filing, the company stated that the new facility is expected to become operational within July 2025.

The plant will add 200 tonne per annum (TPA) to Anuh Pharma’s production capacity, increasing it from 2,200 TPA to 2,400 TPA. Additionally, the INT-1A block includes 40 kiloliters (KL) of reactor capacity, strengthening the company’s infrastructure to meet growing market demand more efficiently.

Anuh Pharma, part of the Rs 8.5 billion SK Group of Companies, is a leading manufacturer of bulk drugs (APIs), specialising in macrolides, anti-TB products, anti-bacterials, anti-malarials, and corticosteroids. Established in 1960, the company employs over 2,000 people across various business segments.